Defining disease modification in myelofibrosis in the era of targeted therapy by Pemmaraju, N, Verstovsek, S, Mesa, R, Gupta, V, Garcia, JS, Scandura, JM, Oh, ST, Passamonti, F, Döhner, K, Mead, AJ

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies by Mughal, TI, Pemmaraju, N, Psaila, B, Radich, J, Bose, P, Lion, T, Kiladjian, J-J, Rampal, R, Jain, T, Verstovsek, S, Yacoub, A, Cortes, JE, Mesa, R, Saglio, G, van Etten, RA